Skip to main content

Advertisement

Log in

Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider–patient communication

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

To assess the impact of patient–provider communication on adherence to tamoxifen (TAM) and aromatase inhibitors (AIs) 36 months after breast cancer (BC) diagnosis in a low-income population of women. California statewide surveys were conducted among 921 low-income women with BC at 6, 18, and 36 months after BC diagnosis. A subset of 303 women with stage I–III BC who initiated hormone treatment after diagnosis was identified. Bivariate and multivariate logistic regression analyses were performed, and adjusted adherence rates were calculated. The main outcome measure was self-reported hormone use at 36 months after BC diagnosis and the chief independent variables were patient-centered communication after diagnosis by patient report as measured by the Consumer Assessment of Healthcare Providers and Systems (CAHPS) and patients’ self-efficacy in patient–physician interactions (PEPPI). Overall adherence to TAM/AI was relatively high (88 %). Adjusted rates of adherence were 59 and 94 % for patients with the lowest versus highest scores on the CAHPS communication scale (AOR = 1.22, P = 0.006) and 72 versus 91 % for patients with the lowest and highest rating of PEPPI (AOR = 1.04, P = 0.04). Having at least one comorbid condition also increased the odds of adherence to hormonal therapy (AOR = 3.14, P = 0.03). Having no health insurance and experiencing side-effects from hormone treatment were barriers for adherence (AOR = 0.12, P = 0.001; AOR = 0.26, P = 0.003, respectively). Patient-centered communication and perceived self-efficacy in patient–physician interaction were significantly associated with patient adherence to ongoing TAM/AI therapy among low-income women with BC. Interventions on patient–provider communication may provide opportunities to improve patient outcomes in this vulnerable population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365:1687–1717

    Article  Google Scholar 

  2. Winer EP, Hudis C, Burstein HJ et al (2005) American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol 23:619–629

    Article  PubMed  CAS  Google Scholar 

  3. Bickell NA, Wang JJ, Oluwole S et al (2006) Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol 24:1357–1362

    Article  PubMed  Google Scholar 

  4. Kimmick G, Anderson R, Camacho F et al (2009) Adjuvant hormonal therapy use among insured, low-income women with breast cancer. J Clin Oncol 27:3445–3451

    Article  PubMed  Google Scholar 

  5. Gotay C, Dunn J (2011) Adherence to long-term adjuvant hormonal therapy for breast cancer. Expert Rev Pharmacoecon Outcomes Res 11(6):709–715

    Article  PubMed  Google Scholar 

  6. Ziller V, Kalder M, Albert US et al (2009) Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Ann Oncol 20(3):431–436

    Article  PubMed  CAS  Google Scholar 

  7. Partridge AH, Wang PS, Winer EP et al (2003) Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 21:602–660

    Article  PubMed  CAS  Google Scholar 

  8. Lash TL, Fox MP, Westrup JL, Fink AK, Silliman RA (2006) Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat 99:215–220

    Article  PubMed  Google Scholar 

  9. Hershman DL, Shao T, Kushi LH et al (2011) Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126(2):529–537

    Article  PubMed  CAS  Google Scholar 

  10. Kahn KL, Schneider EC, Malin JL, Adams JL, Epstein AM (2007) Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use. Med Care 45(5):431–439

    Article  PubMed  Google Scholar 

  11. Fink AK, Gurwitz J, Rakowski W, Guadagnoli E, Silliman RA (2004) Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. J Clin Oncol 22(16):3309–3315

    Article  PubMed  Google Scholar 

  12. Demissie S, Silliman RA, Lash TL (2001) Adjuvant tamoxifen: predictors of use, side effects, and discontinuation on older women. J Clin Oncol 19(2):322–328

    PubMed  CAS  Google Scholar 

  13. Barron TI, Connolly R, Bennett K, Feely J, Kennedy MJ (2007) Early discontinuation of tamoxifen: a lesion for oncologists. Cancer 109(5):831–839

    Article  Google Scholar 

  14. Grunfeld EA, Hunter MS, Sikka P, Mittal S (2005) Adherence beliefs among breast cancer patients taking tamoxifen. Patient Educ Couns 59(1):97–102

    Article  PubMed  Google Scholar 

  15. Piette JD, Heisler M, Krein S, Kerr EA (2005) The role of patient–physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med 165(15):1749–1755

    Article  PubMed  Google Scholar 

  16. Pellegrini I, Sarradon-Eck A, Soussan PB et al (2010) Women’s perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients’ point of view. Psychooncology 19(5):472–479

    Article  PubMed  Google Scholar 

  17. Kirk MC, Hudis CA (2008) Insight into barriers against optimal adherence to oral hormonal therapy in women with breast cancer. Clin Breast Cancer 8(2):155–161

    Article  PubMed  Google Scholar 

  18. Levenstein JH, McCracken EC, McWhinney IR, Stewart MA, Brown JB (1986) The patient-centered clinical method. 1. A model for the doctor–patient interaction in family medicine. Fam Pract 3:24–30

    Article  PubMed  CAS  Google Scholar 

  19. Mead N, Bower P (2000) Patient-centeredness: a conceptual framework and review of the empirical literature. Soc Sci Med 51:1087–1110

    Article  PubMed  CAS  Google Scholar 

  20. Epstein RM, Franks P, Shields CG et al (2005) Patient-centered communication and diagnostic testing. Ann Fam Med 3(5):415–421

    Article  PubMed  Google Scholar 

  21. Epstein RM, Street RL (2007) Patient-centered communication in cancer care: promoting healing and reducing suffering, National Cancer Institute, Bethesda, MD; NIH Publication No. 07-6225

  22. Little P, Everitt H, Williamson I et al (2001) Observational study of effect of patient centeredness and positive approach on outcomes of general practice consultations. Br Med J 323(7318):908–911

    Article  CAS  Google Scholar 

  23. Maly RC, Umezawa Y, Leake B, Silliman RA (2004) Determinants of participation in treatment decision-making by older breast cancer patients. Breast Cancer Res Treat 85(3):201–209

    Article  PubMed  Google Scholar 

  24. Joslyn SA (2002) Racial differences in treatment and survival from early-stage breast carcinoma. Cancer 95(8):1759–1766

    Article  PubMed  Google Scholar 

  25. Hershman D, McBride R, Jacobson JS et al (2005) Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol 23(27):6639–6646

    Article  PubMed  Google Scholar 

  26. Maly R, Liu Y, Kwong E, Thind A, Diamant A (2009) Breast reconstructive surgery in medically underserved women with breast cancer: the role of patient–physician communication. Cancer 115(20):4819–4827

    Article  PubMed  Google Scholar 

  27. Maly RC, Liu Y, Leake B, Thind A, Diamant AL (2010) Treatment-related symptoms among underserved women with breast cancer: the impact of physician–patient communication. Breast Cancer Res Treat 119(3):707–716

    Article  PubMed  Google Scholar 

  28. Maly RC, Stein JA, Umezawa Y, Leake B, Anglin MD (2008) Racial/ethnic group differences in breast cancer outcomes among older patients: effects of physician communication and patient empowerment. Health Psychol 27(6):728–736

    Article  PubMed  Google Scholar 

  29. Davidson B, Vogel V, Wickerham L (2007) Oncologist–patient discussion of adjuvant hormonal therapy in breast cancer: results of a linguistic study focusing on adherence and persistence to therapy. J Support Oncol 5(3):139–143

    PubMed  Google Scholar 

  30. Livaudais JC, Hwang ES, Karliner L et al (2012) Adjuvant hormonal therapy use among women with ductal carcinoma in situ. J Womens Health (Larchmt) 21(1):35–42

    Article  Google Scholar 

  31. Chen JY, Diamant AL, Thind A, Maly RC (2008) Determinants of breast cancer knowledge among newly diagnosed, low-income, medically underserved women with breast cancer. Cancer 112(5):1153–1161

    Article  PubMed  Google Scholar 

  32. Hargraves JL, Hays RD, Cleary PD (2003) Psychometric properties of the Consumer Assessment of Health Plans Study (CAHPS) 2.0 Adult Core Survey. Health Serv Res 38(6 pt 1):1509–1527

    Article  PubMed  Google Scholar 

  33. Hurtado MP, Angeles J, Blahut SA, Hays RD (2005) Assessment of the equivalence of the Spanish and English versions of the CAHPS Hospital Survey on the quality of inpatient care. Health Serv Res 40(6 Pt 2):2140–2161

    Article  PubMed  Google Scholar 

  34. Maly RC, Frank JC, Marshall GN, DiMatteo MR, Reuben DB (1998) Perceived efficacy in patient–physician interactions (PEPPI): validation of an instrument in older persons. J Am Geriatr Soc 46:889–894

    PubMed  CAS  Google Scholar 

  35. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34(1):73–84

    Article  PubMed  CAS  Google Scholar 

  36. Marin G, Sabogal F, Marin B et al (1987) Development of a short acculturation scale for Hispanics. Hisp J Behav Sci 9:183–205

    Article  Google Scholar 

  37. Bernstein R (2005) Hispanic population passes 40 million: census bureau reports. U.S. Census Bureau News, U.S. Department of Commerce, Washington, D.C. http://www.census.gov/population/www/cen2000/briefs.html. Accessed 9 Sept 2010

  38. Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A (2008) Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26(4):556–562

    Article  PubMed  CAS  Google Scholar 

  39. Hershman DL, Kushi LH, Shao T et al (2010) Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol 28(27):4120–4128

    Article  PubMed  Google Scholar 

  40. Balogh EP, Ganz PA, Murphy SB, Nass SJ, Ferrell BR, Stovall E (2011) Patient-centered cancer treatment planning: improving the quality of oncology care. Summary of an institute of medicine workshop. Oncologist 16(12):1800–1805

    Article  PubMed  Google Scholar 

  41. Karliner LS, Hwang ES, Nickleach D, Kaplan CP (2011) Language barriers and patient-centered breast cancer care. Patient Educ Couns 84(2):223–228

    Article  PubMed  Google Scholar 

  42. Roundtree AK, Giordano SH, Price A, Suarez-Almazor ME (2011) Problems in transition and quality of care: perspectives of breast cancer survivors. Support Care Cancer 19(12):1921–1929

    Article  PubMed  Google Scholar 

  43. Anderson R, Barbara A, Feldman S (2007) What patients want: a content analysis of key qualities that influence patient satisfaction. J Med Pract Manage 22(5):255–261

    PubMed  Google Scholar 

  44. Cleary PD, Edgman-Levitan S, Roberts M et al (1991) Patients evaluate their hospital care: a national survey. Health Aff (Millwood) 10(4):254–267

    Article  CAS  Google Scholar 

  45. Cluze C, Rey D, Huiart L et al (2012) Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time. Ann Oncol 23:882–890

    Article  PubMed  CAS  Google Scholar 

  46. Gradishar WJ (2005) Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women. Oncology 69(1):1–9

    Article  PubMed  Google Scholar 

  47. Henry NL, Azzouz F, Desta Z et al (2012) Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. J Clin Oncol 30(9):936–942

    Article  PubMed  CAS  Google Scholar 

  48. Zeber JE, Miller AL, Copeland LA et al (2011) Medication adherence, ethnicity, and the influence of multiple psychosocial and financial barriers. Adm Policy Ment Health 38(2):86–95

    Article  PubMed  Google Scholar 

  49. Yang Y, Thumula V, Pace PF, Banahan BF 3rd, Wilkin NE, Lobb WB (2009) Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study. Clin Ther 31(10):2178–2188

    Article  PubMed  Google Scholar 

  50. Gellad WF, Haas JS, Safran DG (2007) Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med 22(11):136–145

    Article  Google Scholar 

  51. Janz NK, Hawley ST, Mujahid MS et al (2011) Correlates of worry about recurrence in a multi-ethnic population-based sample of women with breast cancer. Cancer 117(9):1827–1836

    Article  PubMed  Google Scholar 

  52. Chen NE, Meyer JP, Avery AK et al (2011) Adherence to HIV treatment and care among previously homeless jail detainees. AIDS Behav (in press)

  53. Rahman SM, Dignan MB, Shelton BJ (2003) Factors influencing adherence to guidelines for screening mammography among women aged 40 years and older. Ethn Dis 13(4):477–484

    PubMed  Google Scholar 

  54. Grieco EM, Cassidy RC. Overview of race and Hispanic origin. U.S. Census Bureau, Census 2000 Brief (issued March 2001): Census 2000 Redistricting (Public Law 94-171) Summary File, Tables PL1 and PL2. U.S. Department of Commerce, Washington, D.C. http://www.census.gov/population/www/cen2000/briefs.html Accessed 9 Sept 2010

  55. Malin JL, Schneider E, Epstein A et al (2006) Quality of care for breast cancer and colorectal cancer: results of the National Initiative for cancer Care Quality. J Clin Oncol 24:626–634

    Article  PubMed  Google Scholar 

  56. Kahn KL, Adams JL, Weeks JC et al (2010) Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA 303:1037–1045

    Article  PubMed  CAS  Google Scholar 

  57. Der Wiel AB, Van Exel E, De Craen AJ et al (2002) A high response is not essential to prevent selection bias: results from the Leiden 85-plus study. J Clin Epidemiol 55(11):1119–1125

    Article  Google Scholar 

  58. Keeter S, Miller C, Kohut A et al (2006) Consequence of reducing nonresponse in a national telephone survey. Public Opin Q 70:759–779

    Article  Google Scholar 

  59. Liu Y, Diamant AL, Thind A, Maly R (2010) Validity of self-reports of breast cancer treatment in low-income medically underserved women with breast cancer. Breast Cancer Res Treat 119:745–751

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by the American Cancer Society (# TURSG-02-081), the California Breast Cancer Research Program (# 7PB-0070), and the National Cancer Institute (#R01CA119197-01A1). Dr. Maly was additionally supported by the National Cancer Institute (#R01CA140481-01A1).

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rose C. Maly.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, Y., Malin, J.L., Diamant, A.L. et al. Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider–patient communication. Breast Cancer Res Treat 137, 829–836 (2013). https://doi.org/10.1007/s10549-012-2387-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-012-2387-8

Keywords

Navigation